Sign Up to like & get
recommendations!
2
Published in 2022 at "American Journal of Transplantation"
DOI: 10.1111/ajt.17121
Abstract: The cilgavimab−tixagevimab combination retains a partial in vitro neutralizing activity against the current SARS‐CoV‐2 variants of concern (omicron BA.1, BA.1.1, and BA.2). Here, we examined whether preexposure prophylaxis with cilgavimab−tixagevimab can effectively protect kidney transplant…
read more here.
Keywords:
tixagevimab;
tixagevimab 150;
cilgavimab;
kidney transplant ... See more keywords